Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Free Cash Flow (2016 - 2026)

Organogenesis Holdings has reported Free Cash Flow over the past 10 years, most recently at $34.8 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 358.92% year-over-year to $34.8 million; the TTM value through Dec 2025 reached -$24.5 million, down 685.73%, while the annual FY2025 figure was -$24.5 million, 685.73% down from the prior year.
  • Free Cash Flow for Q4 2025 was $34.8 million at Organogenesis Holdings, up from $844000.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $40.2 million in Q4 2021 and troughed at -$36.5 million in Q2 2025.
  • A 5-year average of $1.8 million and a median of $3.8 million in 2024 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: soared 392.24% in 2021 and later plummeted 2667.58% in 2025.
  • Year by year, Free Cash Flow stood at $40.2 million in 2021, then tumbled by 151.13% to -$20.6 million in 2022, then skyrocketed by 135.47% to $7.3 million in 2023, then increased by 3.92% to $7.6 million in 2024, then skyrocketed by 358.92% to $34.8 million in 2025.
  • Business Quant data shows Free Cash Flow for ORGO at $34.8 million in Q4 2025, $844000.0 in Q3 2025, and -$36.5 million in Q2 2025.